Acesso livre
Acesso livre

Cardiologia

Revisão | Diagnóstico e tratamento da hipertensão arterial pulmonar.

14 Abr, 2022 | 17:48h

Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review – JAMA (gratuito por tempo limitado)

Revisão clínica em áudio: Diagnosis and Treatment of Pulmonary Arterial Hypertension – JAMA

 

Comentário no Twitter

 


M-A | Inibidores de SGLT2 estão associados com risco reduzido de hiperpotassemia em pessoas com diabetes tipo 2.

14 Abr, 2022 | 17:44h

Sodium-glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 diabetes: A Meta-analysis of Individual Participant Data from Randomized Controlled Trials – Circulation


Estudo de coorte | Diâmetro aumentado da aorta torácica está associado com risco aumentado de eventos cardiovasculares e mortalidade entre mulheres e homens.

14 Abr, 2022 | 17:34h

Thoracic Aortic Diameter and Cardiovascular Events and Mortality among Women and Men – Radiology

Comunicado de imprensa: Increased aortic diameter raises risk of heart attack, stroke – Radiological Society of North America


Interação entre antagonistas do receptor de mineralocorticoide e empagliflozina na insuficiência cardíaca: análise secundária do estudo EMPEROR-Reduced.

14 Abr, 2022 | 17:27h

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced – Journal of the American College of Cardiology

Editorial: Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care


Breve revisão | Endocardite infecciosa: pontos de atenção no tratamento.

14 Abr, 2022 | 17:26h

Infective Endocarditis: Words of Caution For Management – American College of Cardiology

Conteúdos relacionados:

Randomized Trial: Partial Oral vs. Intravenous Antibiotic Treatment of Endocarditis

Cohort Study: Socio-economic variations determine the clinical presentation, etiology and outcome of infective endocarditis.

Podcast: Infective Endocarditis Pearls.

AHA Statement: Prevention of Viridans Group Streptococcal Infective Endocarditis – Antibiotic prophylaxis for invasive dental procedures is suggested only for high-risk patients with the following conditions: 1) cardiac prosthetic valve; 2) previous infective endocarditis; 3) congenital heart disease; or 4) previous heart transplant

New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis

Review: Infective endocarditis after surgical and transcatheter aortic valve replacement

Infective Endocarditis: A Contemporary Review

Summary: Current AATS Guidelines on Surgical Treatment of Infective Endocarditis

Review: Current Evidence on Oral Antibiotics for Infective Endocarditis

[Abstract Only] Prevalence of Infective Endocarditis in Patients with Positive Blood Cultures According to the Organism

Observational Study Suggests Early Surgery is Associated with Reduced Mortality in Patients with Infective Endocarditis and Large Vegetation

Research: Invasive Procedures Associated With the Development of Infective Endocarditis

Meta-Analysis: Association of Vegetation Size With Embolic Risk in Patients With Infective Endocarditis

Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement


Estudo identifica quais tratamentos estão associados com risco aumentado de doença cardíaca entre mulheres com câncer de mama.

14 Abr, 2022 | 17:20h

Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)

Comentário: Major study links breast cancer treatment with increased risk of cardiovascular disease – Fred Hutch

 

Comentário no Twitter

 


Revisão | Intervenção coronariana percutânea (ICP) em pacientes com insuficiência cardíaca: evidências atuais, impacto da revascularização completa e técnicas contemporâneas para melhorar os desfechos.

14 Abr, 2022 | 17:18h

PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes – JSCAI

 

Comentário no Twitter

(Imagens e artigo sob licença de CC BY 4.0)


Estudo randomizado | Rivaroxabam profilático por 30 dias para prevenir trombo ventricular esquerdo após infarto do miocárdio com elevação do segmento ST.

14 Abr, 2022 | 17:17h

Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction – JACC: Cardiovascular Interventions (link para o resumo – $ para o texto completo)


M-A | Inibidores de SGLT2 reduzem internações em pacientes com insuficiência cardíaca independentemente da presença de diabetes.

14 Abr, 2022 | 17:02h

Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: SGLT2 inhibitors reduces hospitalization for heart failure regardless of presence of diabetes – American College of Physicians


Diretriz científica AHA | Infecção por SARS-CoV-2 e manifestações cardiovasculares associadas em crianças e jovens adultos.

14 Abr, 2022 | 16:59h

SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association – Circulation

Comunicado de imprensa: Heart issues after COVID-19 uncommon in children and young adults, more research needed – American Heart Association

Comentário: COVID-19 CV Complications in Children Are Rare, Treatable: AHA Statement – TCTMD


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.